abstract |
The present invention provides a new class of non-immunosuppressive FK506 analogs, which are FKBP selective, small molecule BMP agonists with modest potential therapeutic theories for tissue repair and regeneration. Methods for making and using these compounds are also disclosed herein. [Selection diagram] FIG. 5A |